Apoptosis, subcellular particles, and autoimmunity

Clinical Immunology

Volumn 112, Issue 2, 2004, Pages 175-182

  Cline, Amy M ^a   Radic, Marko Z ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Apoptosis; Apoptotic bodies; Autoantibodies; Blebs; Subcellular particles

Indexed keywords

AUTOANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; TISSUE SPECIFICITY;

EID: 3042753858     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.02.017     Document Type: Article

References (86)

1. Kerr J.F. History of the events leading to the formulation of the apoptosis concept. Toxicology. 181-182:2002;471-474
2. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257
3. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematous are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1994;1317-1330
4. Hargraves M.M., Richmond H., Morton R. Presentation of two bone marrow elements; the 'tart' cell and 'LE' cell. Proc. Staff Meet. Mayo Clin. 23:1948;25-28
5. Kanai Y., Yamauchi S., Hashiba-Kanai Y. Lupus erythematous cell formation by a monoclonal antibody derived from an autoimmune MRL/Mp-lpr/lpr mouse. Immunol. Lett. 20:1989;9-13
6. Hargraves M.M. Discovery of the LE cell and its morphology. Mayo Clin. Proc. 44:1969;579-599
7. Somersan S., Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell Biol. 155:2001;501-504
8. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788
9. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108:2001;957-962
10. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216
11. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:2000;85-90
12. Peiser L., Mukhopadhyay S., Gordon S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14:2002;123-128
13. Becq F., Hamon Y., Bajetto A., Gola M., Verrier B., Chimini G. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J. Biol. Chem. 272:1997;2695-2699
14. Moffatt O.D., Devitt A., Bell E.D., Simmons D.L., Gregory C.D. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J. Immunol. 162:1999;6800-6810
15. Hoffmann P.R., deCathelineau A.M., Ogden C.A., Leverrier Y., Bratton D.L., Daleke D.L., Ridley A.J., Fadok V.A., Henson P.M. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell Biol. 155:2001;649-659
16. Balasubramanian K., Schroit A.J. Characterization of phosphatidylserine- dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J. Biol. Chem. 273:1998;29272-29277
17. Bouma B., de Groot P.G., van den Elsen J.M., Ravelli R.B., Schouten A., Simmelink M.J., Derksen R.H., Kroon J., Gros P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 18:1999;5166-5174
18. Harper M.F., Hayes P.M., Lentz B.R., Roubey R.A. Characterization of beta2-glycoprotein I binding to phospholipid membranes. Thromb. Haemost. 80:1998;610-614
19. Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome. N. Engl. J. Med. 346:2002;752-763
20. Rand J.H. The antiphospholipid syndrome. Annu. Rev. Med. 54:2003;409-424
21. Price B.E., Rauch J., Shia M.A., Walsh M.T., Lieberthal W., Gilligan H.M., O'Laughlin T., Koh J.S., Levine J.S. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J. Immunol. 157:1996;2201-2208
22. Levine J.S., Subang R., Koh J.S., Rauch J. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. J. Autoimmun. 11:1998;413-424
23. Stern M., Savill J., Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol. 149:1996;911-921
24. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268:1993;4569-4572
25. Szalai A.J., Agrawal A., Greenhough T.J., Volanakis J.E. C-reactive protein: structural biology, gene expression, and host defense function. Immunol. Res. 16:1997;127-136
26. Reid K.B. Proteins involved in the activation and control of the two pathways of human complement. Biochem. Soc. Trans. 11:1983;1-12
27. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today. 17:1996;532-540
28. Wright J.R. Immunomodulatory functions of surfactant. Physiol. Rev. 77:1997;931-962
29. Sugimoto R., Yae Y., Akaiwa M., Kitajima S., Shibata Y., Sato H., Hirata J., Okochi K., Izuhara K., Hamasaki N. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 273:1998;20721-20727
30. Thiel S., Reid K.B. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett. 250:1989;78-84
31. Arlaud G.J., Gaboriaud C., Thielens N.M., Budayova-Spano M., Rossi V., Fontecilla-Camps J.C. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol. Immunol. 39:2002;383-394
32. Kim S.J., Gershov D., Ma X., Brot N., Elkon K.B. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann. N. Y. Acad. Sci. 987:2003;68-78
33. Jiang H.X., Siegel J.N., Gewurz H. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J. Immunol. 146:1991;2324-2330
34. Kim S.J., Gershov D., Ma X., Brot N., Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 196:2002;655-665
35. Chang M.K., Binder C.J., Torzewski M., Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc. Natl. Acad. Sci. U. S. A. 99:2002;13043-13048
36. Familian A., Zwart B., Huisman H.G., Rensink I., Roem D., Hordijk P.L., Aarden L.A., Hack C.E. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167:2001;647-654
37. Bickerstaff M.C., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J., Walport M.J., Pepys M.B. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:1999;694-697
38. Burlingame R.W., Volzer M.A., Harris J., Du Clos T.W. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J. Immunol. 156:1996;4783-4788
39. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., Walport M.J. Systemic lupus erythematous, complement deficiency, and apoptosis. Adv. Immunol. 76:2000;227-324
40. Bell S.A., Faust H., Schmid A., Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin. Exp. Immunol. 113:1998;327-332
41. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematous revisited. J. Immunol. 158:1997;4525-4528
42. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194:2001;781-795
43. Gershov D., Kim S., Brot N., Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192:2000;1353-1364
44. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192:2000;359-366
45. Dini L., Pagliara P., Carla E.C. Phagocytosis of apoptotic cells by liver: a morphological study. Microsc. Res. Tech. 57:2002;530-540
46. Hume D.A., Robinson A.P., MacPherson G.G., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J. Exp. Med. 158:1983;1522-1536
47. Opferman J.T., Korsmeyer S.J. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4:2003;410-415
48. Hiramine C., Nakagawa T., Miyauchi A., Hojo K. Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice. Lab. Invest. 75:1996;185-201
49. Cortes-Hernandez J., Fossati-Jimack L., Carugati A., Potter P.K., Walport M.J., Cook H.T., Botto M. Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin. Exp. Immunol. 130:2002;459-466
50. Mitchell D.A., Taylor P.R., Cook H.T., Moss J., Bygrave A.E., Walport M.J., Botto M. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J. Immunol. 162:1999;5676-5679
51. Shui Y.B., Sasaki H., Pan J.H., Hata I., Kojima M., Yamada Y., Hirai K.I., Takahashia N., Sasaki K. Morphological observation on cell death and phagocytosis induced by ultraviolet irradiation in a cultured human lens epithelial cell line. Exp. Eye Res. 71:2000;609-618
52. Parnaik R., Raff M.C., Scholes J. Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr. Biol. 10:2000;857-860
53. Hashimoto S., Ochs R.L., Rosen F., Quach J., McCabe G., Solan J., Seegmiller J.E., Terkeltaub R., Lotz M. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc. Natl. Acad. Sci. U. S. A. 95:1998;3094-3099
54. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344:2001;1140-1144
55. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59
56. Paul E., Pozdnyakova O.O., Mitchell E., Carroll M.C. Anti-DNA autoreactivity in C4-deficient mice. Eur. J. Immunol. 32:2002;2672-2679
57. Vandivier R.W., Ogden C.A., Fadok V.A., Hoffmann P.R., Brown K.K., Botto M., Walport M.J., Fisher J.H., Henson P.M., Greene K.E. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:2002;3978-3986
58. Garred P., Voss A., Madsen H.O., Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematous patients. Genes Immun. 2:2001;442-450
59. Szalai A.J., Weaver C.T., McCrory M.A., Van Ginkel F.W., Reiman R.M., Kearney J.F., Marion T.N., Volanakis J.E. Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum. 48:2003;1602-1611
60. Lu Q., Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 293:2001;306-311
61. Lu Q., Gore M., Zhang Q., Camenisch T., Boast S., Casagranda F., Lai C., Skinner M.K., Klein R., Matsushima G.K., Earp H.S., Goff S.P., Lemke G. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 398:1999;723-728
62. Nakano T., Ishimoto Y., Kishino J., Umeda M., Inoue K., Nagata K., Ohashi K., Mizuno K., Arita H. Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272:1997;29411-29414
63. Anderson H.A., Maylock C.A., Williams J.A., Paweletz C.P., Shu H., Shacter E. Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4:2003;87-91
64. Cohen P.L., Caricchio R., Abraham V., Camenisch T.D., Jennette J.C., Roubey R.A., Earp H.S., Matsushima G., Reap E.A. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196:2002;135-140
65. Lemke G., Lu Q. Macrophage regulation by Tyro 3 family receptors. Curr. Opin. Immunol. 15:2003;31-36
66. Loeser R.F., Varnum B.C., Carlson C.S., Goldring M.B., Liu E.T., Sadiev S., Kute T.E., Wallin R. Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage. Arthritis Rheum. 40:1997;1455-1465
67. Katagiri M., Hakeda Y., Chikazu D., Ogasawara T., Takato T., Kumegawa M., Nakamura K., Kawaguchi H. Mechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts. J. Biol. Chem. 276:2001;7376-7382
68. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077
69. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27:2002;534-539
70. Upchurch H.F., Conway E., Patterson M.K. Jr., Maxwell M.D. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J. Cell. Physiol. 149:1991;375-382
71. Szondy Z., Sarang Z., Molnar P., Nemeth T., Piacentini M., Mastroberardino P.G., Falasca L., Aeschlimann D., Kovacs J., Kiss I., Szegezdi E., Lakos G., Rajnavolgyi E., Birckbichler P.J., Melino G., Fesus L. Transglutaminase 2-/-mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 100:2003;7812-7817
72. Mevorach D., Zhou J.L., Song X., Elkon K.B. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188:1998;387-392
73. Bondanza A., Zimmermann V.S., Dell'Antonio G., Dal Cin E., Capobianco A., Sabbadini M.G., Manfredi A.A., Rovere-Querini P. Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 170:2003;24-27
74. Radic M.Z., Cocca B.A., Cline A.M. Apoptosis in the induction of autoimmunity. Zouali M. Frontiers in Autoimmunity, Fundamental Aspects and Clinical Perspectives. 2003;144-167 IOS Press, Amsterdam, The Netherlands
75. Earnshaw W.C., Martins L.M., Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:1999;383-424
76. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1999;1028-1042
77. Utz P.J., Gensler T.J., Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Res. 2:2000;101-114
78. Lu L., Osmond D.G. Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow. Immunol. Rev. 175:2000;158-174
79. Surh C.D., Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 372:1994;100-103
80. Maekawa T., Kajihara H., Okabayashi K., Otani M., Yuge O. Impairment of splenic B and T lymphocytes in the early period after severe thermal injury: immunohistochemical and electron microscopic analysis. Burns. 28:2002;329-339
81. Lieberthal W., Koh J.S., Levine J.S. Necrosis and apoptosis in acute renal failure. Semin. Nephrol. 18:1998;505-518
82. Cocca B.A., Cline A., Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 168:2002;159-166
83. Cocca B.A., Seal S.N., D'Agnillo P., Mueller Y.M., Katsikis P.D., Rauch J., Weigert M., Radic M.Z. Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;13826-13831
84. A.M. Cline, M.Z. Radic, Murine lupus autoantibodies identify distinct subsets of apoptotic bodies, Autoimmunity, in press.
85. Monestier M., Kandiah D.A., Kouts S., Novick K.E., Ong G.L., Radic M.Z., Krilis S.A. Monoclonal antibodies from NZW × BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J. Immunol. 156:1996;2631-2641
86. Sorice M., Circella A., Misasi R., Pittoni V., Garofalo T., Cirelli A., Pavan A., Pontieri G.M., Valesini G. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin. Exp. Immunol. 122:2000;277-284